MB "Žemės terapija" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 0 |
| - |
| 0 |
| 0 |
| - |
| - |
| - |
| 0 |
| 0 |
| 0 |
| 0 |
| - |
| - |
| - |
| - |
| - |
| 0 |
| 2024 |
|---|
| 4,530 |
| - |
| 1,222 |
| 1,222 |
| - |
| 58.30 |
| 26.98 |
| 1,222 |
| 72 |
| 0 |
| 1,294 |
| 0.27 |
| 0.06 |
| - |
| - |
| 26.98 |
| 1,222 |
| 2025 |
|---|
| 16,400 |
| - |
| 196 |
| 196 |
| - |
| 13.94 |
| 1.20 |
| -4,132 |
| 9,008 |
| 0 |
| 4,876 |
| -0.25 |
| -2.18 |
| - |
| - |
| 1.20 |
| 196 |
| 2025 |
|---|
| 16,400 |
| - |
| 196 |
| 196 |
| - |
| 13.94 |
| 1.20 |
| -4,132 |
| 9,008 |
| 0 |
| 4,876 |
| -0.25 |
| -2.18 |
| - |
| - |
| 1.20 |
| 196 |
Turnover (€)
2025
Turnover (€)
16,400 €262 % *
Sales per employee (€)
-Profit before tax (€)
196 €-84 % *
Net Profit (€)
196 €-84 % *
Profit per employee (€)
-Total profitability (%)
13.94 %-76.09 % *
Net profitability (%)
1.20 %-95.55 % *
Equity (€)
-4,132 €-438 % *
Amounts Payable And Liabilities (€)
9,008 €12,411 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
4,876 €277 % *
Working capital requirement
-0.25 -192.59 % *
Debt-to-equity ratio
-2.18 -3,733.33 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
1.20 %-95.55 % *
EBIT (€)
196 €-84 % *
